Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Maria Capelli

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
Journal of Medicinal Chemistry|November 7, 2009
1,2,4-Triazolyl azabicyclo[3.1.0]hexanes: a new series of potent and selective dopamine D(3) receptor antagonistsFabrizio Micheli, Luca Arista, Giorgio Bonanomi, et al.
ACS Medicinal Chemistry Letters|November 20, 2024
Design, Synthesis, and Activity of a Novel Series of Pyridazine-Based ALK5 InhibitorsDaniele Pala, Paolo Ronchi, Donatella Rescigno, et al.
Chemmedchem|November 15, 2007
Heteroaryl-substituted 4-(1H-pyrazol-1-yl)-5,6-dihydro-1H-pyrrolo[2,3-d]pyrimidine derivatives as potent and selective corticotropin-releasing factor receptor-1 antagonistsFabio Maria Sabbatini, Romano Di Fabio, Yves St-Denis, et al.
Chemmedchem|March 6, 2007
Cyclopenta[d]pyrimidines and dihydropyrrolo[2,3-d]pyrimidines as potent and selective corticotropin-releasing factor 1 receptor antagonistsRoberto Arban, Roberto Benedetti, Giorgio Bonanomi, et al.
Journal of Medicinal Chemistry|May 19, 2026
Discovery of a Novel Lung-Restricted ALK5 Inhibitor for the Treatment of Idiopathic Pulmonary FibrosisPaolo Ronchi, Daniela Pizzirani, Daniele Pala, et al.
Journal of Medicinal Chemistry|February 20, 2026
A Journey through Scaffolds: Indolines, Pyrrolidines, and Azetidines in the Quest for Inhaled DDR Inhibitors for IPFLaura Carzaniga, Andrea Rizzi, Roberta Mazzucato, et al.
Journal of Medicinal Chemistry|December 5, 2024
Discovery of CHF-6523, an Inhaled Selective PI3Kδ Inhibitor for the Treatment of Chronic Obstructive Pulmonary DiseasePaolo Bruno, Daniele Pala, Alessandra Micoli, et al.
Journal of Medicinal Chemistry|September 18, 2007
1,2,4-triazol-3-yl-thiopropyl-tetrahydrobenzazepines: a series of potent and selective dopamine D(3) receptor antagonistsFabrizio Micheli, Giorgio Bonanomi, Frank E Blaney, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Journal of Medicinal Chemistry|November 7, 2009
1,2,4-Triazolyl azabicyclo[3.1.0]hexanes: a new series of potent and selective dopamine D(3) receptor antagonistsFabrizio Micheli, Luca Arista, Giorgio Bonanomi, et al.
ACS Medicinal Chemistry Letters|November 20, 2024
Design, Synthesis, and Activity of a Novel Series of Pyridazine-Based ALK5 InhibitorsDaniele Pala, Paolo Ronchi, Donatella Rescigno, et al.
Chemmedchem|November 15, 2007
Heteroaryl-substituted 4-(1H-pyrazol-1-yl)-5,6-dihydro-1H-pyrrolo[2,3-d]pyrimidine derivatives as potent and selective corticotropin-releasing factor receptor-1 antagonistsFabio Maria Sabbatini, Romano Di Fabio, Yves St-Denis, et al.
Chemmedchem|March 6, 2007
Cyclopenta[d]pyrimidines and dihydropyrrolo[2,3-d]pyrimidines as potent and selective corticotropin-releasing factor 1 receptor antagonistsRoberto Arban, Roberto Benedetti, Giorgio Bonanomi, et al.
Journal of Medicinal Chemistry|May 19, 2026
Discovery of a Novel Lung-Restricted ALK5 Inhibitor for the Treatment of Idiopathic Pulmonary FibrosisPaolo Ronchi, Daniela Pizzirani, Daniele Pala, et al.
Journal of Medicinal Chemistry|February 20, 2026
A Journey through Scaffolds: Indolines, Pyrrolidines, and Azetidines in the Quest for Inhaled DDR Inhibitors for IPFLaura Carzaniga, Andrea Rizzi, Roberta Mazzucato, et al.
Journal of Medicinal Chemistry|December 5, 2024
Discovery of CHF-6523, an Inhaled Selective PI3Kδ Inhibitor for the Treatment of Chronic Obstructive Pulmonary DiseasePaolo Bruno, Daniele Pala, Alessandra Micoli, et al.
Journal of Medicinal Chemistry|September 18, 2007
1,2,4-triazol-3-yl-thiopropyl-tetrahydrobenzazepines: a series of potent and selective dopamine D(3) receptor antagonistsFabrizio Micheli, Giorgio Bonanomi, Frank E Blaney, et al.
Pageof 4